Erratum: Neuroimmune pharmacology from a neuroscience perspective (Journal of Neuroimmune Pharmacology DOI: 10.1007/s11481-010-9239-2);Neuroimmune pharmacology from a neuroscience perspective

Journal of Neuroimmune Pharmacology

Volumn 6, Issue 1, 2011, Pages 10-19

  Northrup, Nicole A ^a   Yamamoto, Bryan K ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Inflammation; Neurodegeneration; Neurogenesis; Neuroplasticity

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; NERVE CELL ADHESION MOLECULE; NEUROIMMUNOPHILIN; NEUROTOXIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALZHEIMER DISEASE; BRAIN FUNCTION; BRAIN INFECTION; DEGENERATIVE DISEASE; DRUG ABUSE; DRUG MECHANISM; HUMAN; IMMUNE SYSTEM; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROIMMUNOLOGY; NEUROPHARMACOLOGY; NEUROPROTECTION; NEUROSCIENCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY;

EID: 79251615551     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-010-9244-5     Document Type: Erratum

References (82)

1. H Akiyama S Barger S Barnum B Bradt J Bauer GM Cole NR Cooper P Eikelenboom M Emmerling BL Fiebich CE Finch S Frautschy WS Griffin H Hampel M Hull G Landreth L Lue R Mrak IR Mackenzie PL McGeer MK O'Banion J Pachter G Pasinetti C Plata-Salaman J Rogers R Rydel Y Shen W Streit R Strohmeyer I Tooyoma FL Van Muiswinkel R Veerhuis D Walker S Webster B Wegrzyniak G Wenk T Wyss-Coray 2000 Inflammation and Alzheimer's diseases Neurobiol Aging 21 83 421
2. J Bauer H Wekerle H Lassmann 1995 Apoptosis in brain specific autoimmune disease Curr Opin Immunol 7 839 843 1:CAS:528:DyaK28XnsFKjtw%3D%3D 10.1016/0952-7915(95)80057-3 8679129 (Pubitemid 26038526)
3. L Boulanger 2009 Immune proteins in brain development and synaptic plasticity Neuron 64 93 109 1:CAS:528:DC%2BD1MXhsFajsbbN 10.1016/j.neuron.2009. 09.001 19840552
4. GC Brown 2007 Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase Biochem Soc Trans 35 5 1119 1121 1:CAS:528:DC%2BD2sXht1eru7rI 10.1042/BST0351166 17956292 (Pubitemid 350206452)
5. AJ Bruce-Keller JL Keeling JN Keller FF Huang S Camondola MP Mattson 1999 Antiinflammatory effects of estrogen on microglial activation Endocrinology 141 10 3646 3656 10.1210/en.141.10.3646
6. S Burstein 2005 PPAR-gamma: a nuclear receptor with affinity for cannabinoids Life Sci 77 14 1674 1684 1:CAS:528:DC%2BD2MXmvVGit7Y%3D 10.1016/j.lfs.2005.05.039 16005906 (Pubitemid 41073661)
7. O Butovsky Y Ziv A Schwartz G Landa AE Talpalar S Pluchino G Martino M Schwartz 2006 Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells Mol Cell Neurosci 31 149 160 1:CAS:528:DC%2BD28XksFGjug%3D%3D 10.1016/j.mcn.2005.10.006 16297637 (Pubitemid 43049908)
8. GA Cabral 2006 Drugs of abuse, immune modulation, and AIDS J Neuroimmune Pharmacol 1 280 295 10.1007/s11481-006-9023-5 18040805 (Pubitemid 44244133)
9. Z Cai Y Pang S Lin PG Rhodes 2003 Differential roles of tumor necrosis-alpha and interleukin-1 beta in lipopolysaccharide induced brain injury in the neonatal rat Brain Res 975 37 47 1:CAS:528:DC%2BD3sXjvV2lsLg%3D 10.1016/S0006-8993(03)02545-9 12763591 (Pubitemid 36588550)
10. D Cederberg P Siesjö 2010 What has inflammation to do with traumatic brain injury? Childs Nerv Syst 26 221 226 10.1007/s00381-009-1029-x 19940996
11. RC Chang K Chiu Y Ho K Sp 2009 Modulation of neuroimmune responses on glia in the central nervous system: implication in therapeutic intervention against neuroinflammation Cell Mol Immunol 6 5 317 326 1:CAS:528: DC%2BD1MXhsF2isbfN 10.1038/cmi.2009.42 19887044
12. J Chen JB Buchanan NL Sparkman JP Godbout GG Feund RW Johnson 2008 Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system Brain Behav Immun 22 301 311 1:CAS:528:DC%2BD1cXhsFyls7s%3D 10.1016/j.bbi.2007.08.014 17951027 (Pubitemid 351172703)
13. CY Chung H Seo KC Sonntag A Brooks L Lin O Isacson 2005 Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection Hum Mol Genet 14 1709 1725 1:CAS:528:DC%2BD2MXmvV2htL8%3D 10.1093/hmg/ddi178 15888489 (Pubitemid 41418045)
14. K Conant C St Hillaire C Anderson D Galey J Wang A Nath 2004 Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases J Neurovirol 10 1 21 28 1:CAS:528:DC%2BD2cXhsFajsLY%3D 10.1080/13550280490261699 14982725 (Pubitemid 38325106)
15. RA Daynes DC Jones 2002 Emerging roles of PPARs in inflammation and immunity Nat Rev Immunol 2 10 748 759 1:CAS:528:DC%2BD38XnsVGqsbY%3D 10.1038/nri912 12360213 (Pubitemid 37328715)
16. C Dello Russo AI Boullerne V Garvrilyuk DL Feinstein 2004 Inhibition of micorglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1β production J Neuroinflammation 1 1 9 10.1186/1742-2094-1-9 15285793 (Pubitemid 39130325)
17. A De Luigi C Fragiacomo U Lucca P Quadri M Tettamanti M Grazia De Simoni 2001 Inflammatory markers in Alzheimer's disease and multi-infarct dementia Mech Ageing Dev 122 1985 1995 10.1016/S0047-6374(01)00313-X 11589916 (Pubitemid 32925108)
18. S Dhawan BS Weeks C Soderland HW Schnaper LA Toro SP Asthana IK Hewlett WG Stetler-Stevenson SS Yamada KM Yamada MS Meltzer 1995 HIV-1 infection alters monocyte interactions with human microvascular endothelial cells J Immunol 154 1 422 432 1:CAS:528:DyaK2MXivVSgs7c%3D 7527819
19. EJ Downer TR Cowley F Cox FO Maher V Berezin E Bock MA Lynch 2009 A synthetic NCAM-derived mimetic peptide, FGL, exerts anti-inflammatory properties via IGF-1 and interferon-gamma modulation J Neurochem 109 1516 1525 1:CAS:528:DC%2BD1MXntVCisL4%3D 10.1111/j.1471-4159.2009.06076.x 19457161
20. J Ehrhart D Obregon T Mori H Hou N Sun Y Bai T Klein F Fernandez J Tan RD Shytle 2005 Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation J Neuroinflammation 2 29 42 10.1186/1742-2094-2-29 16343349 (Pubitemid 41829868)
21. EA Eugenin K Osiecki L Lopez H Goldstein TM Calderon JW Berman 2006 CCL2/Monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS J Neurosci 26 4 1098 1106 1:CAS:528:DC%2BD28XhsVSjsLY%3D 10.1523/JNEUROSCI.3863-05.2006 16436595 (Pubitemid 43237041)
22. G Flora YW Lee A Nath B Hennig W Maragos M Toborek 2003 Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain Exp Neurol 179 1 60 70 1:CAS:528: DC%2BD38Xps12ku7s%3D 10.1006/exnr.2002.8048 12504868 (Pubitemid 36062619)
23. EM Frohman TC Frohman B Vayuvegula S Gupta S van den Noort 1988 Vasoactive intestinal polypeptide inhibits the expression of the MHC class II antigens on astrocytes J Neurol Sci 88 1-3 339 346 1:CAS:528:DyaL1MXhtVyls70%3D 10.1016/0022-510X(88)90230-4 3265718 (Pubitemid 19016608)
24. A Gerhard N Paves G Hotton F Turkheimer M Es A Hammers K Eggert W Oertel RB Banati DJ Brooks 2006 In vivo imaging of microglial activation with [11C]R-PK11195 PET in idiopathic Parkinson's disease Neurobiol Dis 21 404 412 1:CAS:528:DC%2BD28XmsVGmsg%3D%3D 10.1016/j.nbd.2005.08.002 16182554 (Pubitemid 43099863)
25. RS Ghirnikar YL Lee LF Eng 1998 Inflammation in traumatic brain injury: role of cytokines and chemokines Neurochem Res 23 329 340 1:CAS:528: DyaK1cXos1Cnsw%3D%3D 10.1023/A:1022453332560 9482245 (Pubitemid 28109878)
26. CK Glass K Saijo B Winner MC Marchetto FH Gage 2010 Mechanisms underlying inflammation in neurodegeneration Cell 140 918 934 1:CAS:528: DC%2BC3cXlsVSgu7Y%3D 10.1016/j.cell.2010.02.016 20303880
27. BG Gold JG Nutt 2002 Neuroimmunophilin ligands in the treatment of Parkinson's disease Curr Opin Pharmacol 2 82 86 1:CAS:528:DC%2BD38XptV2ltA%3D%3D 10.1016/S1471-4892(01)00125-4 11786313
28. J Gonçalves T Martins R Ferreira N Milhazes F Borges CF Ribeiro JO Malva TR Macedo AP Silva 2008 Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain Ann NY Acad Sci 1139 103 111 10.1196/annals.1432.043 18991854
29. J Gonçalves S Baptista T Martins N Milhazes F Borges CF Ribeiro JO Malva AP Silva 2010 Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin Eur J Neurosci 31 2 315 326 10.1111/j.1460-9568.2009.07059.x 20074221
30. JP Gong ES Onaivi H Ishiguro QR Liu PA Tagliaferro A Brusco GR Uhl 2006 Cannabinoid CB2 receptors: immunohistochemical localization in rat brain Brain Res 1071 1 10 23 1:CAS:528:DC%2BD28XhvVWmtbg%3D 10.1016/j.brainres.2005.11.035 16472786 (Pubitemid 43255471)
31. A Halle V Hornung GC Petzold GR Stewart BG Monks T Reinheckel KA Fitzgerald E Latz KJ Moore DR Golenbock 2008 The NALP3 infammasome in involved in the innate immune response to amyloid-beta Nat Immunol 9 857 865 1:CAS:528:DC%2BD1cXoslCmu74%3D 10.1038/ni.1636 18604209
32. M Herkenham AB Lynn MD Little MR Johnson LS Melvin BR de Costa KC Rice 1990 Cannabinoid receptor localization in brain Proc Natl Acad Sci 87 5 1932 1936 1:CAS:528:DyaK3cXhsFWktLs%3D 10.1073/pnas.87.5.1932 2308954
33. WF Hickey BL Hsu H Kimura 1991 T-lymphocyte entry into the central nervous system J Neurosci Res 28 254 260 1:STN:280:DyaK3M3jslOnug%3D%3D 10.1002/jnr.490280213 2033653
34. EC Hirsch S Hunot 2009 Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8 383 397 10.1016/S1474-4422(09)70062-6
35. B Holtmann S Wiese M Samsam K Grohmann D Pennica R Martini M Sendtner 2005 Triple knock-out of CNTF, LIF, and CT-1 defines cooperative and distinct roles of these neurotrophic factors for motoneuron maintenance and function J Neurosci 25 7 1778 1787 1:CAS:528:DC%2BD2MXhvFGqu7s%3D 10.1523/JNEUROSCI.4249- 04.2005 15716414 (Pubitemid 40279283)
36. GS Huh LM Boulanger H Du PA Riquelme TM Brotz CJ Shatz 2000 Functional requirement for class I MHC in CNS development and plasticity Science 290 5499 2155 2159 1:CAS:528:DC%2BD3cXptVyitr4%3D 10.1126/science.290.5499.2155 11118151 (Pubitemid 32001597)
37. T Iuvone G Esposito D De Filippis C Scuderi L Steardo 2009 Cannabidiol: a promising drug for neurodegenerative disorders? CNS Neursci Ther 15 1 65 75 1:CAS:528:DC%2BD1MXjvFOnsb0%3D 10.1111/j.1755-5949.2008.00065.x
38. JF Ji BP He ST Dheen SS Tay 2004 Expressoin of chemokine receptors CSCR4, CCR2, CCR5, and CX3CR1 in neural progenitor cells isolated from the subventricular zone of the adult rat brain Neuroci Lett 355 236 240 1:CAS:528:DC%2BD2cXltV2lsQ%3D%3D 10.1016/j.neulet.2003.11.024 (Pubitemid 38368746)
39. HJ Kadhim J Duchateau G Sebire 2008 Cytokines and brain injury: invited review J Intensive Care Med 23 236 249 10.1177/0885066608318458 18504260
40. HS Kim YH Suh 2009 Minocylcine and neurodegenerative disease Behav Brain Res 196 168 179 1:CAS:528:DC%2BD1cXhsFaht7%2FE 10.1016/j.bbr.2008.09.040 18977395
41. LY Kong MK McMillian PM Hudson L Jin JS Hong 1997 Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures J Pharmacol Exp Ther 280 1 61 66 1:CAS:528:DyaK2sXntVSksg%3D%3D 8996182
42. H Lassmann W Bruck C Lucchinetti 2001 Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy Trends Mol Med 7 115 121 1:CAS:528:DC%2BD3MXivVGls7Y%3D 10.1016/S1471-4914(00)01909-2 11286782 (Pubitemid 32201673)
43. SC Lee M Collins P Vanguri ML Shin 1992 Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia J Immunol 148 11 3391 3397 1:CAS:528:DyaK38XksVWit7c%3D 1350289
44. X Li G Stark 2002 NFκB-dependent signaling pathways Exp Hematol 30 285 296 1:CAS:528:DC%2BD38XisV2rurw%3D 10.1016/S0301-472X(02)00777-4 11937262 (Pubitemid 34286432)
45. B Liu HM Gao JS Hong 2003 Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of Neuroinflammation Environ Health Perspect 111 1065 1073 1:CAS:528: DC%2BD3sXlvF2ksro%3D 10.1289/ehp.6361 12826478
46. KT Lu YW Wang JT Yang YL Yang HI Chen 2005 Effect of interleukin-1 on traumatic brain injury-induced damage to hippocampal neurons J Neurotrauma 22 885 895 10.1089/neu.2005.22.885 16083355 (Pubitemid 41153873)
47. S-M Lucas NJ Rothwell RM Gibson 2006 The role of inflammation in CNS injury and disease Br J Pharmacol 147 S232 S240 1:CAS:528:DC%2BD28XisVCnsQ%3D%3D 10.1038/sj.bjp.0706400 16402109 (Pubitemid 43077281)
48. KM Lucin T Wyss-Coray 2009 Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64 110 123 1:CAS:528:DC%2BD1MXhsFajsbbO 10.1016/j.neuron.2009.08.039 19840553
49. SJ Lupien F Maheu M Tu A Fiocco TE Schramek 2007 The effects of stress and stress hormones on human cognition: implications for the field of brain cognition Brain Cogn 65 209 237 1:STN:280:DC%2BD2snmvVagug%3D%3D 10.1016/j.bandc.2007.02.007 17466428 (Pubitemid 350051538)
50. WF Maragos KL Young JT Turchan M Guseva JR Pauly A Nath WA Cass 2002 Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function J Neurochem 83 4 955 963 1:CAS:528:DC%2BD38XovFOisb0%3D 10.1046/j.1471-4159.2002.01212.x 12421368 (Pubitemid 35316046)
51. PL McGeer S Itagaki BE Boyes EG McGeer 1988 Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1285 1291 1:STN:280:DyaL1c3ovVKkuw%3D%3D 3399080
52. SO McGuire ZD Ling JW Lipton CE Sortwell TJ Collier PM Carvey 2001 Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons Exp Neurol 169 219 230 1:CAS:528:DC%2BD3MXjsF2ltbg%3D 10.1006/exnr.2001.7688 11358437 (Pubitemid 32524418)
53. DJ Myer GG Gurkof SM Lee DA Hovda MV Sofroniew 2006 Essential protective roles of astrocytes in traumatic brain injury Brain 129 2761 2772 1:STN:280:DC%2BD28rntVKntA%3D%3D 10.1093/brain/awl165 16825202 (Pubitemid 44523749)
54. Nagatsu T, Mogi M, Ishinose H, Togari A (2000) Cytokines in Parkinson's disease. J Neural Transm Suppl 143-151
55. T Nagayama AD Sinor RP Simon J Chen SH Graham K Jin DA Greenberg 1999 Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures J Neurosci 19 8 2987 2995 1:CAS:528:DyaK1MXitlGnur0%3D 10191316
56. A Nakajima K Yamada T Nagai T Uchiyama Y Miyamoto T Mamiya J He A Nitta M Mizuno MH Tran A Seto M Yoshimura K Kitaichi T Hasegawa K Saito Y Yamada M Seishima K Sekikawa HC Kim T Nabeshima 2004 Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity J Neurosci 24 9 2212 2225 1:CAS:528:DC%2BD2cXitlCrtbo%3D 10.1523/JNEUROSCI.4847-03.2004 14999072 (Pubitemid 38314553)
57. H Neumann T Misgeld K Matsumuro H Wekerle 1998 Neurotrophins inhibit major histocompatibility class II inducibility of micoglia: involvement of the p75 neurotrophin receptor Proc Natl Acad Sci USA 95 5779 5784 1:CAS:528:DyaK1cXjtFWrsrk%3D 10.1073/pnas.95.10.5779 9576961 (Pubitemid 28224173)
58. L Orio E O'Shea V Sanchez JM Pradillo I Escobedo J Camarero MA Moro AR Green MI Colado 2004 3, 4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion J Neurochem 89 1445 1453 1:CAS:528:DC%2BD2cXlsVOhtbY%3D 10.1111/j.1471-4159.2004.02443.x 15189347 (Pubitemid 38802666)
59. SE O'Sullivan 2007 Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors Br J Pharmacol 152 5 576 582 10.1038/sj.bjp.0707423 17704824 (Pubitemid 350034977)
60. VH Perry PB Andersson S Gordon 1993 Macrophages and inflammation in the central nervous system Trends Neurosci 16 268 273 1:STN:280:DyaK3szmvFykug%3D%3D 10.1016/0166-2236(93)90180-T 7689770 (Pubitemid 23168847)
61. H Pournajafi Nazarloo T Takao T Taguchi H Ito K Hashimoto 2003 Modulation of type I IL-1 receptor and IL-1 beta mRNA expression followed by endotoxins treatment in the corticotrophin-releasing hormone-deficient mouse J Neuroimmunol 1401 102 108 10.1016/S0165-5728(03)00176-0 (Pubitemid 36836095)
62. BG Ramírez C Blázquez T Gómez del Pulgar M Guzmán ML de Ceballos 2005 Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation J Neurosci 25 8 1904 1913 10.1523/JNEUROSCI.4540-04.2005 15728830 (Pubitemid 40289395)
63. BC Reiner JP Keblesh H Xiong 2009 Methamphetamine abuse, HIV infection, and neurotoxicity Int J Physiol Pathophysiol Pharmacol 1 2 162 179 1:CAS:528:DC%2BD1MXhsVCisr%2FM 20411028
64. NJ Rothwell GN Luheshi 2000 Interleukin-1 in the brain: biology, pathology, and therapeutic target Trends Neurosci 23 618 625 1:CAS:528:DC%2BD3MXhsVymsA%3D%3D 10.1016/S0166-2236(00)01661-1 11137152 (Pubitemid 32007888)
65. A Roumier C Béchade JC Poncer KH Smalla E Tomasello E Vivier ED Gundelfinger A Triller A Bessis 2004 Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse J Neurosci 24 50 11421 11428 1:CAS:528:DC%2BD2MXjtVajsA%3D%3D 10.1523/JNEUROSCI.2251-04.2004 15601948 (Pubitemid 39658277)
66. E Roussa M Wiehle N Dünker S Becker-Katins O Oehlke K Krieglstein 2006 Transforming growth factor beta is required for differentiation of mouse mesencephalic progenitors into dopaminergic neurons in vitro and in vivo: ectopic induction in dorsal mesencephalon Stem Cells 24 9 2120 2129 1:CAS:528:DC%2BD28XhtFKgs7zM 10.1634/stemcells.2005-0514 16741229 (Pubitemid 44477137)
67. M Sastre J Walter SM Gentleman 2008 Interactions between APP secretases and inflammatory mediators J Neuroinflammation 5 25 35 10.1186/1742-2094-5-25 18564425 (Pubitemid 351998123)
68. E Shohami I Ginis JM Hallenbeck 1999 Dual role of tumor necrosis alpha in brain injury Cytokine Growth Factor Rev 10 119 130 1:CAS:528:DyaK1MXmslersrs%3D 10.1016/S1359-6101(99)00008-8 10743503 (Pubitemid 29446376)
69. D Stellwagen EC Beattie JY Seo RC Malenka 2005 Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha J Neurosci 25 12 3219 3228 1:CAS:528:DC%2BD2MXivFGhsb0%3D 10.1523/JNEUROSCI.4486- 04.2005 15788779 (Pubitemid 40463557)
70. B Stevens NJ Allen LE Vazquez GR Howell KS Christopherson N Nouri KD Micheva AK Mehalow AD Huberman B Stafford A Sher AM Litke JD Lambris SJ Smith SW John BA Barres 2007 The classical complement cascade mediates CNS synapse elimination Cell 131 6 1164 1178 1:CAS:528:DC%2BD1cXksFGnsw%3D%3D 10.1016/j.cell.2007.10.036 18083105 (Pubitemid 350235022)
71. WJ Streit KR Miller KO Loeps E Njie 2008 Microglial degeneration in the aging brain-bad news for neurons? Front Biosci 13 3424 3438
72. R Stumm C Zhou T Ara F Lazarini M Dubois-Dalcq T Nagasawa V Höllt S Schulz 2003 CXCR4 regulates interneuron migration in the developing neocortex J Neurosci 23 12 5123 5130 1:CAS:528:DC%2BD3sXltlent7c%3D 12832536
73. Y Sun SPH Alexander MJ Garle CL Gibson K Hewitt SP Murphy DA Kendall AJ Bennett 2007 Cannabinoid activation of PPARα; a novel neuroprotective mechanism Br J Pharmacol 152 5 734 743 1:CAS:528:DC%2BD2sXht1ejt77F 10.1038/sj.bjp.0707478 17906680 (Pubitemid 350034991)
74. JL Tchelingerian L Vignais C Jacque 1994 TNF alpha gene expression is induced in neurons after a hippocampal lesion NeuroReport 5 585 588 1:STN:280:DyaK2c3pslWrsA%3D%3D 10.1097/00001756-199401000-00013 8025249
75. R Tehranian S Andell-Jonsson SM Beni I Yatsiv E Shohami T Bartfai J Lundkvist K Iverfeldt 2002 Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist J Neurotrauma 19 939 951 10.1089/089771502320317096 12225654
76. DM Thomas J Dowgiert TJ Geddes D Francescutti-Verbeem X Liu DM Kuhn 2004 Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines Neurosci Lett 367 3 349 354 1:CAS:528:DC%2BD2cXntFWqtbY%3D 10.1016/j.neulet.2004.06.065 15337264 (Pubitemid 39178611)
77. S Walter M Letiembre Y Liu H Heine B Penke W Hao B Bode N Manietta J Walter W Schulz-Schuffer K Fassbender 2007 Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease Cell Physiol Biochem 20 947 956 1:CAS:528:DC%2BD2sXht1Cku7zP 10.1159/000110455 17982277 (Pubitemid 350059737)
78. JD Weaver MH Huang M Albert T Harris JW Rowe TE Seeman 2002 Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging Neurology 59 3 371 378 1:CAS:528:DC%2BD38XmvVarurk%3D 12177370
79. NP Whitney TM Eidem H Peng Y Huang JC Zheng 2009 Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders J Neurochem 108 6 1343 1359 1:CAS:528: DC%2BD1MXjsFWgs7k%3D 10.1111/j.1471-4159.2009.05886.x 19154336
80. D Xu C Hopf R Reddy RW Cho L Guo A Lanahan RS Petralia RJ Wenthold RJ O'Brien P Worley 2003 Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity Neuron 39 3 513 528 1:CAS:528:DC%2BD3sXmsFOks78%3D 10.1016/S0896-6273(03)00463-X 12895424 (Pubitemid 36937051)
81. SD Yan X Chen M Chen H Zhu A Roher T Slattery L Zhao M Nagashima J Morser A Migheli P Nawroth DM Stern A-M Schmidt 1996 RAGE and Abeta peptide neurotoxicity in Alzheimer's disease Nature 382 685 691 1:CAS:528: DyaK28Xlt1yltr0%3D 10.1038/382685a0 8751438 (Pubitemid 26282167)
82. L Zhang Y Shirayama E Shimizu M Iyo K Hashimoto 2006 Protective effects of minocycline on 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain Eur J Pharmacol 544 1-3 1 9 1:CAS:528:DC%2BD28XotV2gsbk%3D 10.1016/j.ejphar.2006.05.047 16859675 (Pubitemid 44148565)